Marta Santamariña
Fundación Pública Galega de Medicina Xenómica
ORCID: 0000-0001-5616-9946Also affiliated with Instituto de Investigación Sanitaria de Santiago, Instituto de Investigación de Enfermedades Raras
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “CDK redundancy guarantees cell cycle progression in RB-negative tumor cells independently of their p16 status”.
Gonzalo Hernández, Juan Zalvide, Marta Santamariña
Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more
Douglas F. Easton, Anne‐Laure Renault, Sean V. Tavtigian, Jonine L. Bernstein, Zsofia Kote‐Jarai +51 more
Valentina Silvestri, Goska Leslie, Timothy R. Rebbeck, Susan L. Neuhausen, John L. Hopper +95 more
Laura Madanat‐Harjuoja, Goska Leslie, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +68 more